TCHP and cancer: In vitro findings on TpMs and Mad2 suggest the need to extend the determination of TpMs levels to a major number of diverse cancer types accompanied by the determination of Mad2 level [32,36], with the purpose of identifying diverse patient phenotypes related to TpMs and Mad2 expression.